The global intrathecal drug market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Intrathecal administration is a method of administration for drugs through an injection into the spinal canal, or into the subarachnoid space in such an order that it reaches the cerebrospinal fluid. It is found to be useful in spinal anesthesia, chemotherapy, or pain management applications. Also known as the “pain pump,” intrathecal drug delivery uses a small pump to deliver pain medication directly to the spinal cord. The pump is surgically placed under the abdominal skin and delivers pain medication through a catheter to the area around spinal cord Intrathecal drugs. These are the drugs that are administered through injection into the spinal canal, or into the subarachnoid space.
As per the NCBI, presently there are only three medications approved by the US Food and Drug Administration (FDA) for use via the intrathecal route. These intrathecal drugs are categorized as morphine, ziconotide, and baclofen. The major factors attributable to the market growth includes the increasing adoption of Intrathecal Drug Delivery (IDD) system along with extensively improved analgesia that are further driving their demand all over the globe. Unavoidable cancer pain treated with dosages of opioids may cause systematic complications such as excessive sedation and pneumonia. On the other hand, intrathecal drug delivery system has less adverse effects when compared to traditional opioid-based treatments which include morphine & morphine – like medications. All these benefits offered by intrathecal drugs are likely to drive the market growth during the forecast period.
(Get 15% Discount on Buying this Report)
Get Sample Copy of Intrathecal Drug market at:
https://orionmarketreports.com/request-sample/?id=94049&submit=Request+Sample%0D%0A
Market Coverage
The market number available for – 2021-2028
Base year- 2021
Forecast period- 2022-2028
Segment Covered-
By Application
By Type
Regions covered-
North America
Europe
Asia-Pacific
Rest of the World
Top Major Key Players:
Fresenius Kabi AG, and TerSera Therapeutics LLC, among others.
Key questions addressed by the report
What is the market growth rate?
Which segment and region dominate the market in the base year?
Which segment and region will project the fastest growth in the market?
How COVID-19 impacted the market?
Deviation from the pre-COVID-19 forecast
Most affected region and segment
Who is the leader in the market?
How are players addressing challenges to sustain growth?
Where is the investment opportunity?
A full report of Intrathecal Drug market is available at:
https://orionmarketreports.com/global-intrathecal-drug-market/94049/
Global Intrathecal Drug Market Report by Segment
By Application
Adult
Child and Teen
By Type
Baclofen Injection
Ziconotide Intrathecal Infusion
Morphine Injection
About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
